Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Concludes $1.7M Acquisition of PRO-DNA Diagnostics

NEW YORK, May 10 (GenomeWeb News) - Warnex, a Quebecois biotechnology company, said yesterday that it has concluded the acquisition of all of the issued and outstanding shares of PRO-DNA Diagnostics.

 

The company said that it paid CA$1.9 million ($1.7 million) for PRO-DNA, CA$1.4 million of which was paid in cash, and CA$500,000 will become payable either in common shares of Warnex or in cash contingent on milestones
that may be achieved in the 25 months following the closing date of the transaction


Warnex announced its intentions to acquire PRO-DNA, a laboratory that offers genetic testing
services, in April.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.